Concepedia

Author

Federico Pulido

Hospital Universitario 12 De OctubreORCID

Also Known As

B Jimeno, Daniel Rodríguez, Enrique Ortega, F Ortega, F Pulido, F Pulido Ortega, F. ORTEGA, F. Ortega, F. Pulido, F. Pulido Ortega

305

Publications

7.6K

Citations

46

H-Index

63

Concepts

All Affiliations

Hospital Universitario 12 De OctubreHospital Universitario La PazResearch Institute Hospital 12 de OctubreInstituto de Salud Carlos IIIHospital Universitario Ramón y Cajal
FP

About

Federico Pulido is an author at Hospital Universitario 12 De Octubre specializing in hiv, medicine, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

32

2.4K

2

Epidemiology

12

13

950

3

Public Health

11

12

682

4

Health Policy

3

3

45

5

Global Health

2

2

30

Federico Pulido

×

103

Publications

5.9K

Citations

41

H-Index

YearCitations

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink,

The Lancet

2013

537

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas,

The Lancet

2018

371

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

José Ramón Arribas, Andrzéj Horban, Jan Gerstoft,

AIDS

2009

183

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

Deanna Kerrigan, Andrea Mantsios, Miguel Górgolas,

PLoS ONE

2018

163

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus

Juan Berenguer, Elisa Boucourt Rodríguez, Pilar Miralles,

Clinical Infectious Diseases

2012

159

Dolutegravir in antiretroviral-naive adults with HIV-1

Hans-Jürgen Stellbrink, Jacques Reynes, Adriano Lazzarin,

AIDS

2013

158

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV

Federico Pulido, José Ramón Arribas, Rafaël Delgado,

AIDS

2008

154

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression

José Ramón Arribas, Federico Pulido, Rafaël Delgado,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2005

149

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

José Ramón Arribas, Pierre‐Marie Girard, Roland Landman,

The Lancet Infectious Diseases

2015

142

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax,

The Lancet HIV

2018

140

Page 1